Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2026-01-27 @ 4:13 PM
Study NCT ID:
NCT00102466
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2005-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLAF237A2338
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None